recombinant parathyroid hormone (1-84) (Natpara)

From Aaushi
Jump to navigation Jump to search

Indications

Dosage

  • injection one a day

Adverse effects

(common)

Mechanism of action

More general terms

Components

References

  1. Greenspan SL, Bone HG, Ettinger MP, Hanley DA, Lindsay R, Zanchetta JR, Blosch CM, Mathisen AL, Morris SA, Marriott TB; Treatment of Osteoporosis with Parathyroid Hormone Study Group. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med. 2007 Mar 6;146(5):326-39. PMID: https://www.ncbi.nlm.nih.gov/pubmed/17339618
  2. 2.0 2.1 2.2 Reuters, Sept 12, 2014 U.S. FDA panel recommends approval of NPS hormone replacement drug. http://news.yahoo.com/u-fda-panel-recommends-approval-nps-hormone-replacement-214259435--finance.html
    FDA News Release. January 23, 2015 FDA approves Natpara to control low blood calcium levels in patients with hypoparathyroidism. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm431358.htm